Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Ovalum |
---|---|
Information provided by: | Ovalum |
ClinicalTrials.gov Identifier: | NCT00618020 |
The CiTop™ guidewire Coronary study is a feasibility open label study, to evaluate the safety and efficacy of the CiTop™ Guidewire for crossing chronic total occlusion in Coronary arteries.
Condition | Intervention |
---|---|
Coronary Occlusion |
Device: CiTop(tm) Guidewire |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Single Group Assignment |
Official Title: | A Feasibility Study to Evaluate the Safety and Efficacy of the CiTop™ Guidewire for Crossing Chronic Total Occlusion in Coronary Arteries |
Enrollment: | 10 |
Study Start Date: | August 2007 |
Study Completion Date: | February 2008 |
Primary Completion Date: | February 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 21 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Ovalum Ltd. ( Clinical Affairs ) |
Study ID Numbers: | 4C-b No. OVC-C01 |
Study First Received: | January 28, 2008 |
Last Updated: | July 17, 2008 |
ClinicalTrials.gov Identifier: | NCT00618020 History of Changes |
Health Authority: | India: Institutional Review Board |
CTO Chronic Total Occlusion Revascularization |
Coronary Disease Coronary Occlusion Heart Diseases Myocardial Ischemia |
Vascular Diseases Ischemia Coronary Artery Disease |
Coronary Disease Coronary Occlusion Heart Diseases |
Myocardial Ischemia Vascular Diseases Cardiovascular Diseases |